The Wharton Moneyball Post Game Podcast

Share

Wharton Moneyball: MLB, Changes to the Baseball & Football Scouting

Ep. 158

Show from 7/10/19


In this episode of Wharton Moneyball the hosts kick off the show discussing the US Women's World Cup victory against the Netherlands! Then

the Clippers, Kawhi Leonard and Paul George shifted the balance of power in the NBA, tune in to hear what the data and analytics tell us about who will succeed and who will falter in the new look league. After that our hosts take a look at how the baseball has changed over time and the effects these changes have on pitchers. Plus the ins and outs of football scouting.


Guests:

Dr. Meredith Wills - A sports data scientist, having transitioned from a previous career in astrophysics. In addition to independent research, she is a Sports Data Product Specialist for SportsMEDIA Technology. 

Follow her on Twitter: @Bbl_Astrophyscs


Dan Hatman - Has worked in player personnel and scouting roles for the Giants, Jets and Eagles and he is currently the Director of Scouting Development at The Scouting Academy. His focus is on the personal and professional development of the next generation of evaluators and enhance the evaluation community.

Follow him on Twitter: @Dan_Hatman

More Episodes

7/22/2020

7/22/2020: COVID-19, Sports, David Fajgenbaum

David Fajgenbaum, MD, MBA, MSc is a groundbreaking physician-scientist, disease hunter, and bestselling author of the acclaimed memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action. Fajgenbaum went from being a beast-like college Quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, he spearheaded an innovative approach to research and discovered a possible treatment that has put him into an extended remission. Now, he is spreading this approach to advance cures for other diseases and sharing lessons he learned about living from nearly dying through Chasing My Cure.One of the youngest individuals ever appointed to the faculty at Penn Medicine and the top 1 percent youngest grant awardees of a leading NIH grant, Dr. Fajgenbaum is co-founder and executive director of the Castleman Disease Collaborative Network (CDCN) and Associate Director, Patient Impact, for the Penn Orphan Disease Center. He has been recognized on the Forbes 30 Under 30 list, as a top healthcare leader by Becker's Hospital Review, the Global Genes RARE Champion of Hope: Science awardee, and one of three recipients--including Vice President Joe Biden--of a 2016 Atlas Award from the World Affairs Council of Philadelphia. Before co-founding the CDCN, Dr. Fajgenbaum co-founded and led the Actively Moving Forward Support Network, a non-profit organization dedicated to supporting grieving college students. Dr. Fajgenbaum has been profiled in a cover story by The New York Times as well as by Good Morning America, CNN, and the Today Show, among others.Dr. Fajgenbaum earned a BS from Georgetown University magna cum laude with honors and distinction, MSc from the University of Oxford, MD from the University of Pennsylvania Medical School, and MBA from The Wharton School. He is a former Division I college quarterback, state-champion weight lifter, and co-founder of a national grief support network.